Matches in Nanopublications for { ?s ?p "[We investigated the prevalence of the JAK2 V617F gain-of-function mutation in patients with Philadelphia chromosome-negative chronic myeloproliferative disorders (Ph- MPD) and explored the links between JAK2 mutational status and the clinicopathologic picture of essential thrombocythemia (ET), chronic idiopathic myelofibrosis (CIMF), and polycythemia vera (PV).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP382015.RAXjznoyMKvwuhkM89PJ_ZkqsaTDbCPz7bHo_LsXEAtgI130_assertion description "[We investigated the prevalence of the JAK2 V617F gain-of-function mutation in patients with Philadelphia chromosome-negative chronic myeloproliferative disorders (Ph- MPD) and explored the links between JAK2 mutational status and the clinicopathologic picture of essential thrombocythemia (ET), chronic idiopathic myelofibrosis (CIMF), and polycythemia vera (PV).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382015.RAXjznoyMKvwuhkM89PJ_ZkqsaTDbCPz7bHo_LsXEAtgI130_provenance.
- NP378710.RAs8La4TwS3Sgi_uBnlT8V97sIv7z5ssC8_r0LuGluHek130_assertion description "[We investigated the prevalence of the JAK2 V617F gain-of-function mutation in patients with Philadelphia chromosome-negative chronic myeloproliferative disorders (Ph- MPD) and explored the links between JAK2 mutational status and the clinicopathologic picture of essential thrombocythemia (ET), chronic idiopathic myelofibrosis (CIMF), and polycythemia vera (PV).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378710.RAs8La4TwS3Sgi_uBnlT8V97sIv7z5ssC8_r0LuGluHek130_provenance.
- NP680932.RAwf2PbjHmw-PIwTkaqEU2r49yOT-IbTX7M7VymLKtR2k130_assertion description "[We investigated the prevalence of the JAK2 V617F gain-of-function mutation in patients with Philadelphia chromosome-negative chronic myeloproliferative disorders (Ph- MPD) and explored the links between JAK2 mutational status and the clinicopathologic picture of essential thrombocythemia (ET), chronic idiopathic myelofibrosis (CIMF), and polycythemia vera (PV).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680932.RAwf2PbjHmw-PIwTkaqEU2r49yOT-IbTX7M7VymLKtR2k130_provenance.
- NP711575.RA_aE1QFTJtSV8CYKpYoA7y-FB33jXRr4kF3m6_wS_BHo130_assertion description "[We investigated the prevalence of the JAK2 V617F gain-of-function mutation in patients with Philadelphia chromosome-negative chronic myeloproliferative disorders (Ph- MPD) and explored the links between JAK2 mutational status and the clinicopathologic picture of essential thrombocythemia (ET), chronic idiopathic myelofibrosis (CIMF), and polycythemia vera (PV).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711575.RA_aE1QFTJtSV8CYKpYoA7y-FB33jXRr4kF3m6_wS_BHo130_provenance.